vs
Orthofix Medical Inc.（OFIX）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是Orthofix Medical Inc.的1.0倍（$225.0M vs $219.9M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs 2.0%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -12.3%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
OFIX vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.0倍
$219.9M
营收增速更快
ROCK
高出23.0%
2.0%
自由现金流更多
ROCK
多$9.4M
$16.8M
两年增速更快
OFIX
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $225.0M |
| 净利润 | $-2.2M | — |
| 毛利率 | 71.1% | 25.3% |
| 营业利润率 | 0.2% | 7.9% |
| 净利率 | -1.0% | — |
| 营收同比 | 2.0% | 24.9% |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXROCK
| Q4 25 | $219.9M | $225.0M | ||
| Q3 25 | $205.6M | $310.9M | ||
| Q2 25 | $203.1M | $309.5M | ||
| Q1 25 | $193.6M | $290.0M | ||
| Q4 24 | $215.7M | $180.1M | ||
| Q3 24 | $196.6M | $277.1M | ||
| Q2 24 | $198.6M | $273.6M | ||
| Q1 24 | $188.6M | $292.5M |
净利润OFIXROCK
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-22.8M | $-89.1M | ||
| Q2 25 | $-14.1M | $26.0M | ||
| Q1 25 | $-53.1M | $21.1M | ||
| Q4 24 | $-29.1M | — | ||
| Q3 24 | $-27.4M | $34.0M | ||
| Q2 24 | $-33.4M | $32.2M | ||
| Q1 24 | $-36.0M | $24.9M |
毛利率OFIXROCK
| Q4 25 | 71.1% | 25.3% | ||
| Q3 25 | 72.2% | 26.6% | ||
| Q2 25 | 68.7% | 28.4% | ||
| Q1 25 | 62.8% | 26.8% | ||
| Q4 24 | 69.0% | 29.0% | ||
| Q3 24 | 68.7% | 29.4% | ||
| Q2 24 | 67.8% | 30.5% | ||
| Q1 24 | 67.5% | 28.9% |
营业利润率OFIXROCK
| Q4 25 | 0.2% | 7.9% | ||
| Q3 25 | -8.3% | 12.8% | ||
| Q2 25 | -7.9% | 12.8% | ||
| Q1 25 | -25.2% | 8.8% | ||
| Q4 24 | -5.3% | 13.3% | ||
| Q3 24 | -9.6% | 15.6% | ||
| Q2 24 | -12.5% | 14.9% | ||
| Q1 24 | -15.6% | 10.8% |
净利率OFIXROCK
| Q4 25 | -1.0% | — | ||
| Q3 25 | -11.1% | -28.6% | ||
| Q2 25 | -6.9% | 8.4% | ||
| Q1 25 | -27.4% | 7.3% | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -13.9% | 12.3% | ||
| Q2 24 | -16.8% | 11.8% | ||
| Q1 24 | -19.1% | 8.5% |
每股收益（稀释后）OFIXROCK
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.57 | $-2.98 | ||
| Q2 25 | $-0.36 | $0.87 | ||
| Q1 25 | $-1.35 | — | ||
| Q4 24 | $-0.76 | — | ||
| Q3 24 | $-0.71 | $1.11 | ||
| Q2 24 | $-0.88 | $1.05 | ||
| Q1 24 | $-0.95 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $450.0M | $950.4M |
| 总资产 | $850.6M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资OFIXROCK
| Q4 25 | $82.0M | $115.7M | ||
| Q3 25 | $62.9M | $89.4M | ||
| Q2 25 | $65.6M | $43.3M | ||
| Q1 25 | $58.0M | $25.1M | ||
| Q4 24 | $83.2M | $269.5M | ||
| Q3 24 | $30.1M | $228.9M | ||
| Q2 24 | $26.4M | $179.1M | ||
| Q1 24 | $27.0M | $146.7M |
总债务OFIXROCK
| Q4 25 | — | $0 | ||
| Q3 25 | $157.2M | $0 | ||
| Q2 25 | $157.0M | $0 | ||
| Q1 25 | $156.9M | $0 | ||
| Q4 24 | $157.0M | $0 | ||
| Q3 24 | $118.5M | $0 | ||
| Q2 24 | $118.0M | $0 | ||
| Q1 24 | $118.2M | $0 |
股东权益OFIXROCK
| Q4 25 | $450.0M | $950.4M | ||
| Q3 25 | $442.5M | $951.8M | ||
| Q2 25 | $458.3M | $1.0B | ||
| Q1 25 | $458.3M | $1.0B | ||
| Q4 24 | $503.1M | $1.0B | ||
| Q3 24 | $525.9M | $1.0B | ||
| Q2 24 | $546.0M | $975.7M | ||
| Q1 24 | $570.3M | $940.2M |
总资产OFIXROCK
| Q4 25 | $850.6M | $1.4B | ||
| Q3 25 | $832.6M | $1.4B | ||
| Q2 25 | $837.2M | $1.5B | ||
| Q1 25 | $823.1M | $1.4B | ||
| Q4 24 | $893.3M | $1.4B | ||
| Q3 24 | $867.9M | $1.4B | ||
| Q2 24 | $882.0M | $1.4B | ||
| Q1 24 | $906.0M | $1.3B |
负债/权益比OFIXROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | 0.36× | 0.00× | ||
| Q2 25 | 0.34× | 0.00× | ||
| Q1 25 | 0.34× | 0.00× | ||
| Q4 24 | 0.31× | 0.00× | ||
| Q3 24 | 0.23× | 0.00× | ||
| Q2 24 | 0.22× | 0.00× | ||
| Q1 24 | 0.21× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $26.2M |
| 自由现金流率自由现金流/营收 | 7.6% | 11.7% |
| 资本支出强度资本支出/营收 | 4.9% | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $120.6M |
8季度趋势，按日历期对齐
经营现金流OFIXROCK
| Q4 25 | $27.7M | $35.5M | ||
| Q3 25 | $12.4M | $73.0M | ||
| Q2 25 | $11.6M | $44.9M | ||
| Q1 25 | $-18.4M | $13.7M | ||
| Q4 24 | $23.7M | $19.9M | ||
| Q3 24 | $11.7M | $64.7M | ||
| Q2 24 | $9.0M | $36.5M | ||
| Q1 24 | $-18.6M | $53.2M |
自由现金流OFIXROCK
| Q4 25 | $16.8M | $26.2M | ||
| Q3 25 | $2.5M | $64.8M | ||
| Q2 25 | $4.5M | $27.3M | ||
| Q1 25 | $-25.1M | $2.3M | ||
| Q4 24 | $15.2M | $14.1M | ||
| Q3 24 | $6.3M | $60.5M | ||
| Q2 24 | $-360.0K | $33.5M | ||
| Q1 24 | $-29.1M | $48.8M |
自由现金流率OFIXROCK
| Q4 25 | 7.6% | 11.7% | ||
| Q3 25 | 1.2% | 20.8% | ||
| Q2 25 | 2.2% | 8.8% | ||
| Q1 25 | -13.0% | 0.8% | ||
| Q4 24 | 7.0% | 7.8% | ||
| Q3 24 | 3.2% | 21.8% | ||
| Q2 24 | -0.2% | 12.2% | ||
| Q1 24 | -15.4% | 16.7% |
资本支出强度OFIXROCK
| Q4 25 | 4.9% | 4.1% | ||
| Q3 25 | 4.8% | 2.6% | ||
| Q2 25 | 3.5% | 5.7% | ||
| Q1 25 | 3.5% | 3.9% | ||
| Q4 24 | 4.0% | 3.3% | ||
| Q3 24 | 2.7% | 1.5% | ||
| Q2 24 | 4.7% | 1.1% | ||
| Q1 24 | 5.6% | 1.5% |
现金转化率OFIXROCK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
